markets.financialcontent.com ·
stockstory 2026 5 12 earnings to watch staar surgical staa reports q1 results tomorrow
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedSTAAR Surgical (STAA) is a medical device company focused on implantable lenses. The earnings report may affect its stock price and investor sentiment, but no direct commercial mechanism (e.g., supply chain, input cost, regulation) is triggered. The impact is company-specific and limited to equity valuation.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- STAAR Surgical reports Q1 earnings on Wednesday.
- Previous quarter revenue was $57.8 million, up 18.1% YoY but missed estimates.
- Analysts expect 81.8% revenue growth YoY this quarter.
- Revenue estimates have been revised downward over the past month.
- Current share price $27.74, average analyst target $21.11.
STAAR Surgical's stock price is expected to decline 2-3% within 48 hours due to Q1 earnings miss sentiment.
Sign in to see all sector verdicts, full thesis and counter-argument debate.
Sector impact at a glance
- MEDICAL_DEVICESshort